
ABOUT NOVOTECH
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
FEATURED SOLUTIONS
-
Learn how virtual clinical trials can offer patient retention and cost benefits compared to traditional trials.
-
Accelerate patient recruitment and drug development with real world data (RWD).
-
Novotech’s medical and regulatory consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services.
-
Novotech delivers unmatched experience as the Asia-Pacific’s leading CRO with 11 dedicated offices, expert teams and deep local regulatory knowledge.
-
Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites and investigators for your study.
WEBINARS
-
Industry leaders dive into the FDA’s Diversity Action Plans and practical strategies for integrating diversity action plans into clinical trial operations in a presentation centered around enhancing trial diversity.
-
This presentation aims to equip sponsors, researchers, and stakeholders with the tools to enhance trial resilience and ensure continuity in today’s unpredictable global landscape.
-
Hear from a panel of industry experts on dissecting the shift in early-phase oncology design, focusing on Bayesian Data.
-
Hear from a panel of life science experts about the most recent developments and ground-breaking approaches shaping the field of vaccine development worldwide.
-
The webinar features regulatory affairs and investment leaders from North America and Asia Pacific who will discuss why biotech companies are increasingly exploring clinical opportunities in Asia Pacific to generate diverse, globally accepted clinical trial data, and much more.
-
In this webinar, gain insight into the latest regulatory and clinical developments in the field of oncology in China.
-
This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers.
-
Discover how the clinical research bridge between China and the US supports accelerated clinical development from early to late phase trials while ensuring the inclusion of MRCT data packages in future regulatory applications.
-
China now represents 60% of clinical development in CAR-T therapy development globally: what have we learned to date and where are future opportunities?
WHITE PAPERS
-
Oncolytic virus (OV) While oncolytic virus (OV) therapy holds significant promise, addressing immunological challenges and navigating the evolving regulatory environment are critical for its successful integration into clinical practice.
-
With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.
-
The global vaccine trial landscape is undergoing rapid evolution, driven by technological innovations, emerging health threats, and regulatory shifts.
-
Stay updated on transformative advancements in small cell lung cancer (SCLC) therapies, clinical trials, and targeted drug development.
-
Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.
-
Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect of this disease on the world.
-
Explore the latest advancements in diffuse large B-cell lymphoma research, innovative therapies, and personalized care strategies shaping the future of treatment.
-
Discover the latest in gastric cancer research with this detailed report, highlighting new therapies, clinical trials, and future innovations.
-
Explore the latest advancements in pancreatic cancer research with this comprehensive disease report, covering new treatments, clinical trials, and future innovations in care.
-
This resource offers a detailed analysis of the global RNA trial landscape, highlighting the growth in trials, especially in the Asia-Pacific region, which has seen a 26% annual growth rate.
-
CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.
-
Oesophageal cancer is the 11th most common cancer and the 7th leading cause of cancer deaths, starting in the esophagus. Explore our report to discover the latest in treatments, clinical trials, and future innovations.
-
By downloading this report, readers will uncover the transformative potential of radiopharmaceuticals in cancer therapy and stay ahead in the evolving cancer treatment landscape.
-
Explore cutting-edge Non-Small Cell Lung Cancer (NSCLC) research with Novotech CRO's in-depth disease analysis, providing insights into innovative therapies, clinical trials, and future directions shaping NSCLC care globally.
-
Explore the latest advancements and clinical trial landscape in liver cancer research with Novotech CRO's comprehensive disease report.
-
Gain comprehensive insights into Antibody-Drug Conjugates (ADCs) with our 2024 clinical trial report, offering a deep dive into new drug developments and market trends shaping cancer treatment.
-
Explore the forefront of epilepsy research with Novotech CRO's comprehensive analysis, unveiling innovative therapies, clinical trials, and future trends shaping epilepsy care.
-
Enhance your knowledge of the latest advancements in endometrial cancer research with this CRO disease report, featuring new treatments, clinical trials, and future innovations in care.
-
Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.
-
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Delve into the latest advancements in clinical trials, targeted therapies, and the promising future of cancer care, uncovering innovative treatments shaping oncology.
-
Get a comprehensive overview of the global HIV clinical trial landscape since 2018, showcasing regional leadership, trial phases, and growth rates.
-
Dive into the forefront of immune checkpoint inhibitors clinical trials with an exploration of the latest trends and key findings.
-
Access comprehensive insights and analysis for a deeper understanding of the biotech landscape, including optimism and challenges felt throughout 2023 and what the future could hold.
-
Gain in-depth insights into infectious diseases-based clinical trials and be better informed about trends, regional disparities, technological advancements, and financing dynamics.
-
Discover why the collaboration and expertise of organizations are vital in advancing rare disease research and improving the lives of millions affected.
-
Dive into how the advancements in technology are heralding a brighter future for patients worldwide, offering new hope and improved healthcare outcomes.
-
Explore the global landscape of oncolytic virus clinical trials, with a particular focus on trends in the Asia Pacific region.
-
Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.
-
Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.
-
Learn about the global clinical trial landscape of multi-specific monoclonal antibodies (Mabs), with emphasis on trends in the Asia Pacific, and recent advancements in the field.
-
Get an overview of the global approval landscape, pathways to approval, and the importance of a robust clinical development program as made possible with the help of an experienced CRO.
-
Gain a better understanding of the global clinical trial landscape of antibody drug conjugates (ADCs) and their trends in the Asia Pacific.
-
C3 Glomerulopathy (C3G) is a complex, rare complement-mediated renal disease. Find out its effects in the Asia Pacific.
-
Diabetic Retinopathy (DR) is the leading cause of vision loss in working-age populations, and one of the main complications of Diabetes Mellitus (DM). Read about the effects of this disease.
-
The world is heavily burdened by glaucoma, which is the second-leading cause of blindness and the primary cause of irreversible blindness. Learn about its effects in the Asia Pacific.
-
Explore the differences between the common food allergies in Asia and the West, specifically the peanut allergy.
-
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare condition that affects the ability of hematopoietic stem cells and their cellular offspring to bind specific proteins to the cell surface.
-
Explore why the Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions as trial locations
-
Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.
-
In this white paper, learn why western biopharma companies should take advantage of China’s revamped regulatory framework.
-
Next generation sequencing (NGS) refers to a technology that detects genomic variation that is present at birth or emerges later in life. This report describes the availability of NGS in a selection of locations.
-
In this white paper, gain insight into how the Asia Pacific region, with its rapid growth of clinical trials, presents a great opportunity for conducting clinical research and has become the preferred destination for DCTs.
-
Learn how the Asia Pacific has shown significant increase in Immuno-oncology (IO) trials between 2017 and 2021 and contributes to about 35% of clinical development in IO globally.
-
Delve into how China is now more aligned with international standards, enabling biotech firms to streamline processes and timelines, which has significantly recharged biotech innovation.
-
With changing global clinical trials landscape, explore how APAC is emerging as the hot spot for conducting clinical trials, especially in China.
CONTACT INFORMATION
Novotech
Level 19, 66 Goulburn Street
Sydney, NSW 2000
AUSTRALIA
NEWS
- Novotech Releases Comprehensive Report On Oncolytic Virus Therapy
- Novotech Releases Report On Current State Of Triple-Negative Breast Cancer Clinical Trials
- Novotech Releases Report On Global Parkinson's Disease Clinical Trial Landscape
- Novotech Named A Fierce CRO Award Winner In The Excellence In Clinical Trial Management And Global Operations Categories
- Novotech Publishes Report On The Global COVID-19 Clinical Trial Landscape
- Novotech Publishes Comprehensive Report On The Global Vaccine Clinical Trials Landscape
- Novotech Releases Report On Global Bladder Cancer Clinical Trials, Offering Insights For Oncology Advancement
- Novotech Releases Comprehensive Report On The Global Clinical Trial Landscape For Small Cell Lung Cancer (SCLC)
- The Future Of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights From Global Research
- Global Cell And Gene Therapy Trials: Driving Innovation In Oncology And Beyond
- Novotech Releases In-Depth Report On Cervical Cancer: Addressing A Global Health Challenge
- Novotech And Biostar Establish Strategic Partnership Following Biostar's HKEX Listing
- Show Chwan Health Care System Joins Hands With Novotech To Accelerate The Quality Of International Clinical Trials Of New Drugs
- Novotech Recognized For Excellence In Business Expansion, Innovation, And Marketing At The 2024 Clinical Trials Arena Excellence Awards
- Show Chwan Health Care System Joins Novotech To Accelerate The Quality Of International Clinical Trials Of New Drugs
- Novotech Wins Prestigious Brandon Hall Gold Award For CRA Monitoring Simulation Program Under Category Of Best Competencies And Skill Development
- Novotech Appoints Dr. Yooni Kim As A New Executive Position Of Managing Director For APAC To Strengthen Global Expansion
- Novotech Honored With Frost & Sullivan's 2024 Best Practices Company Of The Year Award For Leadership In Biotech CRO Services
- Novotech Unveils 2024 Report On Global Gastric Cancer Clinical Trials And Cutting-Edge Therapeutics
- Novotech Releases 2024 Report On Pancreatic Cancer Clinical Trials And Drug Development
- Transforming The Future Of Medicine With RNA-Based Therapies
- In-Depth Report On Global Oesophageal Cancer Clinical Trials Now Available
- Novotech Earns Renewed Certification As An Employer Of Choice For Gender Equality
- New Report Highlights Global Trends And Advances In Chronic Lymphocytic Leukemia Research And Treatment
- Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
- Novotech Report Analyses Epilepsy Research Trends Finding More than 4,000 Clinical Trials Conducted Globally
- Novotech Publishes Report On Research Into Endometrial Cancer, A Leading Cause Of Gynecology Malignancy Mortality
- Novotech Appoints Dr. Ian Braithwaite As Vice President, Global Project Management To Lead World-Class Clinical Program Operations
- Antibody-Drug Conjugates Shift The Cancer Treatment Landscape: Novotech Whitepaper Examines Latest Clinical Trial Data
- Novotech Announces MOU With Experienced Psychedelics Research Center At The 4th Annual Psychedelic Therapeutics And Drug Development Conference In Boston
- Novotech Launches Dedicated Early Phase Unit For Biotechs Leveraging The Australian And New Zealand Clinical Environment
- Novotech Signs Strategic MOU With Hong Kong-Shenzhen Innovation And Technology Park Limited (HSITPL)
- Novotech Appoints Commercial And Clinical Life Sciences Specialist To Head Up Global Drug Development Consulting Team
- Novotech Publishes Research Report On Acute Myeloid Leukaemia Clinical Trial Landscape For Clinical Stage Biotechs
- Novotech Publishes Analyst Report On Cystic Fibrosis Clinical Trial Landscape To Inform Biotech Research Planning
- Novotech Publishes Duchenne Muscular Dystrophy Landscape Report To Support Biotech Research Planning
- Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends And Opportunities In Targeted Therapies
- Novotech Publishes Candidiasis And Rheumatoid Arthritis Clinical Trial Landscape Reports To Support Biotech Research Planning
- New Novotech Report Finds 1,000 HIV Clinical Trials Globally
- Early-Stage Biotech Investments Were Down 40% In 2023: Novotech Whitepaper
- Novotech Executive Team At J.P. Morgan Healthcare Conference: Global CRO Designed For Biotechs Across 25 Regions
- New Novotech Report On Metastatic Breast Cancer Identifies 1,000 Clinical Trials Globally Since 2018
- Novotech Identifies Decentralized Clinical Trials Potential And Challenges For Accelerating Global Biotech Clinical Trials In 2024
- Novotech Publishes New Reports On Dyslipidaemia And Non-Small Cell Lung Cancer Global Clinical Trial Landscape
- Novotech Publishes Whitepaper On Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide
- Novotech Opens ChinaTrials 15 Conference With Workshop On How Biotechs Can Accelerate Global Trials
- Driving Progress Towards Gender Equality And Inclusion
- Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports On Hemophilia And Primary Biliary Cholangitis
- Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director And Dr. David Ng, Global Vice President Of Biometrics And Data
- Dr. Yooni Kim, Vice President Of Clinical Services At Novotech, Delivers Keynote Address At Veeva Korea Summit
FEATURED REPORTS
-
This guide to clinical trials explores the regulatory approval, study startup, and trial processes essential for advancing medical innovation.
-
Parkinson's disease affects over 8.5 million globally. Explore how advances in gene therapy, Deep Brain Stimulation, and innovative drugs are transforming treatment and improving patient outcomes.
-
Explore how COVID-19 has led to significant global morbidity and mortality. Advances in vaccines, therapies, and clinical trials are enhancing disease management and outcomes.
-
The global vaccine trial landscape is advancing rapidly, driven by new technologies and evolving regulations. Explore the answers to six questions about this rapidly evolving field.
-
Advances in immunotherapy, targeted drugs, and clinical trials are improving outcomes for bladder cancer patients, addressing regional disparities and accessibility challenges worldwide.
-
Small cell lung cancer (SCLC) is a fast-growing, aggressive lung cancer subtype. Global incidence, innovative therapies, and personalized medicine are transforming treatment outcomes and survival rates.
-
Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma subtype, has varied molecular profiles, global incidence, innovative drugs, and trials improving treatment strategies and patient outcomes.
-
The landscape of cell and gene therapy is advancing rapidly, revolutionizing healthcare by offering novel treatments for cancer, rare genetic conditions, and hematological diseases.
-
Gain insights into the evolving landscape of gastric cancer care and examine significant advancements and ongoing challenges in the fight against this formidable disease.
-
Pancreatic cancer, an aggressive gastrointestinal malignancy, presents a significant global health challenge. Delve into the current state of research and discover emerging therapeutic strategies.
-
In this FAQ, we delve into various aspects of Chronic Lymphocytic Leukemia (CLL), including its incidence and prevalence, the latest clinical trials, and the development of innovative drug therapies.
-
Whether you’re a researcher, clinician, or industry professional, our FAQs will equip you with essential knowledge on the advancements and challenges in RNA therapy development.
-
This FAQ delves into the latest advancements in the treatment of oesophageal cancer, highlighting cutting-edge drugs, ongoing clinical trials, and their potential to improve patient outcomes.
-
This FAQ section delves into non-small cell lung cancer (NSCLC) incidence, current trials, innovative drugs, and their effects on patient outcomes.
-
This FAQ examines advancements in liver cancer treatment, emphasizing innovative drugs, current clinical trials, and their potential effects on patient outcomes.
-
This in-depth analysis offers invaluable insights into the evolving field of innovative cancer therapies, addressing your critical questions.
-
Novotech’s vice president emphasizes the expanding clinical presence in the APAC region, with a focus on Australia and South Korea.
-
Take a deep dive into the world of epilepsy, exploring its prevalence, ongoing clinical trials, innovative drugs in development, and ultimately, how these advancements can improve the lives of people living with seizures.
-
Get the inside scoop on how targeted therapies are evolving through clinical trials, new uses, and groundbreaking research.
-
This FAQ delves into the latest developments in endometrial cancer treatment, highlighting innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Uncover developments in cystic fibrosis treatment, focusing on innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Explore how this comprehensive approach can offer hope for improved outcomes and quality of life for DMD patients, highlighting global commitment to tackling this complex disorder.
-
While RA presents a substantial global health challenge, see how evolving therapies and research efforts offer hope for improved outcomes and better management of this debilitating condition.
-
Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.
-
Explore how the research into Rheumatoid Arthritis, which affects 17.6 million people worldwide, aims to improve treatment effectiveness and future interventions.
-
Explore how drug-resistant strains are posing challenges when it comes to the treatment of candidiasis, but therapeutic advancements and ongoing research are offering hope for improved outcomes.
-
Get an overview of the diverse therapeutic modalities in drug development as it relates to the clinical trial landscape and prospects in Candidiasis treatment.
-
Explore the essential considerations for sponsors and CROs as they navigate the advantages and challenges of clinical trial locations, particularly in the United States and Europe.
-
Uncover how ongoing research exploring innovative pathways is serving as a beacon of hope for HIV, promising not only an eventual cure but also an enhanced quality of life for those affected.
-
Uncover why the collaboration between researchers, clinicians, regulatory bodies, and CROs remains crucial for innovative solutions and improved patient outcomes in the journey to address metastatic breast cancer challenges.
-
While APAC is at the forefront of dyslipidaemia research, gain insight into pharmaceutical companies' continued new treatment developments and innovative therapies.
-
Unearth how targeted medicines and immunotherapy have emerged as viable treatment options, offering hope for improved outcomes and quality of life for NSCLC patients.
-
Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.
-
See how the development of new drug classes offers the potential for better PBC management, addressing its global impact.
-
While numerous opportunities are available for companies seeking to undertake CAR-T research in China, understand why embarking on this path requires careful consideration.
-
Explore the exciting advancements in CNG treatment, such as innovative therapies, ongoing clinical trials, and their potential to positively influence patient outcomes.
-
With ongoing technological advancements, consider several factors as to why experts believe that Virtual Clinical Trials will continue to play a significant role even beyond the post-pandemic era, despite its unique set of challenges.
-
Delve into the swiftly evolving trends that are reshaping the clinical trial industry and examine potential implications for introducing innovative solutions to the market.
-
Contract research organizations can be invaluable partners in clinical trials. Dive into the full spectrum of benefits you'll experience by partnering with a globally established and well-resourced CRO.
-
Discover the advantages of incorporating Europe and APAC regions in clinical trial endeavors, such as accelerated recruitment, streamlined regulatory procedures, access to diverse patient populations, and ultimately, significant cost reductions.
-
Learn about ADCs advancements in cancer treatment and how the therapy could potentially revolutionize the field by reducing the often severe side effects associated with traditional chemotherapy.
-
Consider the advantages associated with conducting early- to late-phase clinical trials in China and the broader APAC region, as well as potential challenges that could impact the trial process and patient outcomes
-
Gain insight into how teams can create clinical pathways and develop trial designs made for success.
-
Get a full overview of the role CROs play in clinical trials and their impact on site selection, site monitoring, patient recruitment, managing data, and more.
-
Get an overview of the exciting advancements in gallbladder cancer (GBC) treatment, emphasizing pioneering medications, ongoing clinical trials, and their potential to revolutionize patient outcomes.
-
Explore exciting advancements in the treatment of nasopharyngeal carcinoma (NPC), specifically pharmaceuticals, ongoing clinical trials, and their potential to significantly improve patient prognosis and outcomes.
-
Dive into the global clinical trial landscape of Crohn's disease (CD), its trends in the Asia Pacific, and what the industry is doing to look for a cure.
-
Gain a better understanding of the global clinical trial landscape of Non-Hodgkin lymphoma (NHL) and its trends in the Asia Pacific.
-
Unearth how health officials are preparing to meet the rising demand for resources regarding liver cancer and ensure effective management throughout the cancer pathway.
CASE STUDIES
-
This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.
-
Learn about the success ReveraGen found when expanding their partnership with Novotech to a larger phase 2b trial (VBP15-004) in Duchenne Muscular Dystrophy (DMD).
-
Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.
-
Explore how this partnership aims to contribute to the success of the trial by leveraging global resources and streamlining processes for efficient and timely results.